VOYA Investment Management
LYEL icon

VOYA Investment Management’s Lyell Immunopharma LYEL Stock Holding History

VOYA Investment Management’s Portfolio LYEL Stock Details LYEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,516
Closed -$27.1K – 2707
2025
Q1 		$27.1K Sell
2,516
-131
-5% -$1.6K ﹤0.01% 2604
2024
Q4 		$33.9K Sell
2,647
-130
-5% -$2.58K ﹤0.01% 2717
2024
Q3 		$76.6K Sell
2,777
-152
-5% -$4.47K ﹤0.01% 2712
2024
Q2 		$84.9K Hold
2,929
– – ﹤0.01% 2705
2024
Q1 		$131K Sell
2,929
-731
-20% -$31.3K ﹤0.01% 2571
2023
Q4 		$142K Hold
3,660
– – ﹤0.01% 2673
2023
Q3 		$108K Buy
3,660
+138
+4% +$6.55K ﹤0.01% 2707
2023
Q2 		$224K Buy
3,522
+150
+4% +$8.3K ﹤0.01% 2531
2023
Q1 		$159K Hold
3,372
– – ﹤0.01% 2603
2022
Q4 		$234K Hold
3,372
– – ﹤0.01% 2487
2022
Q3 		$494K Buy
3,372
+91
+3% +$12.3K ﹤0.01% 2032
2022
Q2 		$428K Buy
+3,281
New +$335K ﹤0.01% 1932

Other funds holding LYEL

AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
OPL
Orland Properties Ltd Road Town, Tortola, British Virgin Islands $267M AUM 5.05% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCMV
Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VOYA Investment Management's LYEL Position: Q2 2025 in Review

VOYA Investment Management sold out of Lyell Immunopharma (LYEL) in Q2 2025, closing a stake of 2,516 shares — an estimated $27.1K sold.

VOYA Investment Management first reported a position in LYEL in Q2 2022 and held it in 12 quarters. The position peaked at $494K in Q3 2022. 69 funds tracked by Wall St. Rank hold LYEL as of Q2 2025.

  • VOYA Investment Management reported no remaining Lyell Immunopharma position as of Q2 2025 after selling out during the quarter.
  • VOYA Investment Management sold 2,516 Lyell Immunopharma shares in Q2 2025, an estimated $27.1K.
  • VOYA Investment Management first reported a position in Lyell Immunopharma in Q2 2022 and held it in 12 quarters.
  • VOYA Investment Management's Lyell Immunopharma position peaked at $494K in Q3 2022.
  • 69 funds tracked by Wall St. Rank held Lyell Immunopharma as of Q2 2025.

Based on VOYA Investment Management's 13F filing for Q2 2025, filed 14 Aug 2025.